Compound information
- Natural Products
- ZC370226
- Molecular Formula
- C15H20N2O3S
- Molecular Weight
- 308.1194635 g/mol
- Structure
-
- IUPAC Name
- [4-(benzenesulfonyl)piperazin-1-yl]-[(1R,2R)-2-methylcyclopropyl]methanone
- InChI
- InChI=1S/C15H20N2O3S/c1-12-11-14(12)15(18)16-7-9-17(10-8-16)21(19,20)13-5-3-2-4-6-13/h2-6,12,14H,7-11H2,1H3/t12-,14-/m1/s1
- InChI Key
- SJCNQLYJGPWRSK-TZMCWYRMSA-N
- SMILES
- C[C@@H]1C[C@H]1C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1
- Source
- ZINC000008379661
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 21 | Ring Count | 3 |
| Heteroatom Count | 6 | Rotatable Bond Count | 3 |
| Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 0 |
| Topological Polar Surface Area | 57.69 Å2 | LogP | 1.349 |
| LogS | -2.554 | LogD | 1.791 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.013 | Pgp substrate | 0.412 |
| HIA | 0.968 | F20 % | 0.995 |
| F30 % | 0.947 | Caco-2 | -4.725 |
| MDCK | -4.648 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.476 | PPB | 77.237 |
| VD | 0.849 | Fu | 0.794 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.003 | CYP1A2 substrate | 0.45 |
| CYP2A6 substrate | 0.625 | CYP2B6 substrate | 0.632 |
| CYP2C19 inhibitor | 0.252 | CYP2C19 substrate | 0.727 |
| CYP2C8 substrate | 0.516 | CYP2C9 inhibitor | 0.017 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.003 |
| CYP2D6 substrate | 0.693 | CYP2E1 substrate | 0.961 |
| CYP3A4 inhibitor | 0.067 | CYP3A4 substrate | 0.998 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.546 | CL | 7.062 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.011 | Hepatotoxicity | 0.803 |
| Mutagenicity | 0.059 | Rat Oral Acute Toxicity | 0.295 |
| FDAMDD | 0.62 | Skin Sensitization | 0.007 |
| Carcinogenicity | 0.536 | Eye Corrosion | 0.007 |
| Eye Irritation | 0.386 | Respiratory Toxicity | 0.352 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.193 | IGC50 | 2.638 |
| LC50FM | -1.443 | LC50DM | 2.044 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.236 | NR-AR-LBD | 0.344 |
| NR-AhR | 0.02 | NR-Aromatase | 0.053 |
| NR-ER | 0.253 | NR-ER-LBD | 0.387 |
| NR-PPAR-gamma | 0.101 | SR-ARE | 0.239 |
| SR-ATAD5 | 0.3 | SR-HSE | 0.079 |
| SR-MMP | 0.012 | SR-p53 | 0.042 |
Similar covalent drugs
No similar covalent drugs found for this compound.